Role of peroxisome proliferator-activated receptor γ in amyloid precursor protein processing and amyloid β-mediated cell death

Biochemical Journal

Volumn 391, Issue 3, 2005, Pages 693-698

  D'Abramo, Cristina ^a   Massone, Sara ^a   Zingg, Jean Marc ^b   Pizzuti, Antonio ^c   Marambaud, Philippe ^d   Dalla Piccola, Bruno ^c   Azzi, Angelo ^b   Marinari, Umberto M ^a   Pronzato, Maria A ^a   Ricciarelli, Roberta ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BERN   (Switzerland)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Northwell Health   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein (APP); Amyloid ; Non steroidal anti inflammatory drugs (NSAIDs); Peroxisome proliferator activated receptor (PPAR )

Indexed keywords

CELLS; CORRELATION METHODS; DISEASES;

AMYLOIDS; NECROSIS; NEUROPROTECTION;

PROTEINS;

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; HYDROGEN PEROXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CELL DEATH; CORRELATION ANALYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; NECROSIS; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; UBIQUITINATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE; DOWN-REGULATION; HUMANS; HYDROGEN PEROXIDE; NECROSIS; PPAR GAMMA; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA INTERFERENCE;

EID: 27744510142     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20050560     Document Type: Article

References (27)

1. Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P. et al. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609-1611
2. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L. et al. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421
3. in t'Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. and Stricker, B. H. (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345, 1515-1521
4. Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A. and Cole, G. M. (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 5709-5714
5. Lim, G. P., Yang, F., Chu, T., Gahtan, E., Ubeda, O., Beech, W., Overmier, J. B., Hsiao-Ashec, K., Frautschy, S. A. and Cole, G. M. (2001) Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol. Aging 22, 983-991
6. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T. et al. (2001) A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature (London) 414, 212-216
7. Willson, T. M., Brown, P. J., Sternbach, D. D. and Henke, B. R. (2000) The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43, 527-550
8. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839
9. Perlmann, T. and Evans, R. M. (1997) Nuclear receptors in Sicily: all in the famiglia. Cell 90, 391-397
10. Sastre, M., Dewachter, I., Landreth, G. E., Willson, T. M., Klockgether, T., van Leuven, F. and Heneka, M. T. (2003) Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase. J. Neurosci. 23, 9796-9804
11. Camacho, I. E., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D. and De Strooper, B. (2004) Peroxisome proliterator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide. J. Neurosci. 24, 10908-10917
12. Sagi, S. A., Weggen, S., Eriksen, J., Golde, T. E. and Koo, E. H. (2003) The noncyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of κB kinase, and NFκB, do not reduce amyloid β42 production. J. Biol. Chem. 278, 31825-31830
13. Ricciarelli, R., Zingg, J. M. and Azzi, A. (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 102, 82-87
14. Juge-Aubry, C., Pernin, A., Favez, T., Burger, A. G., Wahli, W., Meier, C. A. and Desvergne, B. (1997) DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem. 272, 25252-25259
15. Rodgers, K. J. and Dean, R. T. (2003) Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates. Int. J. Biochem. Cell Biol. 35, 716-727
16. Marx, N., Duez, H., Fruchart, J. C. and Staels, B. (2004) Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 94, 1168-1178
17. Weggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Ozols, V., Fauq, A., Golde, T. E. and Koo, E. H. (2003) Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity. J. Biol. Chem. 278, 31831-31837
18. Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H. and Golde, T. E. (2003) NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo. J. Clin. Invest. 112, 440-449
19. Checler, F., da Costa, C. A., Ancolio, K., Chevallier, N., Lopez-Perez, E. and Marambaud, P. (2000) Role of the proteasome in Alzheimer's disease. Biochim. Biophys Acta 1502, 133-138
20. Nunan, J., Williamson, N. A., Hill, A. F., Sernee, M. F., Masters, C. L. and Small, D. H. (2003) Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease β-amyloid protein precursor: effect of C-terminal truncation on production of β-amyloid protein. J. Neurosci. Res. 74, 378-385
21. Abbenante, G., Kovacs, D. M., Leung, D. L., Craik, D. J., Tanzi, R. E. and Fairlie, D. P. (2000) Inhibitors of β-amyloid formation based on the β-secretase cleavage site. Biochem. Biophys. Res. Commun. 268, 133-135
22. Yamamoto, R., Yoneda, S. and Hara, H. (2004) Neuroprotective effects of β-secretase inhibitors against rat retinal ganglion cell death. Neurosci. Lett. 370, 61-64
23. Vermes, I., Haanen, C., Steffens-Nakken, H. and Reutelingsperger, C. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184, 39-51
24. Marambaud, P., Lopez-Perez, E., Wilk, S. and Checler, F. (1997) Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's β-amyloid precursor protein: different control of early and late events by the proteasome. J. Neurochem. 69, 2500-2505
25. Flood, F., Murphy, S., Cowburn, R. F., Lannfelt, L., Walker, B. and Johnston, J. A. (2005) Proteasome-mediated effects on amyloid precursor protein processing at the γ-secretase site. Biochem. J. 385, 545-550
26. Qin, C., Burghardt, R., Smith, R., Wormke, M., Stewart, J. and Safe, S. (2003) Peroxisome proliferator-activated receptor γ agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor α in MCF-7 breast cancer cells. Cancer Res. 63, 958-964
27. Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B. and Landreth, G. E. (2000) Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J. Neurosci. 20, 558-567